Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Titel:
Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
Auteur:
Mistry, Pramod K. Balwani, Manisha Baris, Hagit N. Turkia, Hadhami Ben Burrow, T. Andrew Charrow, Joel Cox, Gerald F. Danda, Sumita Dragosky, Marta Drelichman, Guillermo El-Beshlawy, Amal Fraga, Cristina Freisens, Selena Gaemers, Sebastiaan Hadjiev, Evgueniy Kishnani, Priya S. Lukina, Elena Maison-Blanche, Pierre Martins, Ana Maria Pastores, Gregory Petakov, Milan Peterschmitt, M. Judith Rosenbaum, Hanna Rosenbloom, Barry Underhill, Lisa H. Cox, Timothy M.